-
Mashup Score: 213Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture method - 3 day(s) ago
Nature Biotechnology – Off-the-shelf CAR-NKT cells for cancer immunotherapy are advanced toward clinical translation.
Source: www.nature.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 267Linking CRISPR–Cas9 double-strand break profiles to gene editing precision with BreakTag - 3 day(s) ago
Nature Biotechnology – The genome-wide landscape of Cas-induced double-strand breaks and end structures is profiled at nucleotide resolution.
Source: www.nature.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 141
Nature Methods – Molecular Pixelation is an optics-free method that uses DNA-tagged antibodies to enable identification of the relative location of proteins on single cells.
Source: www.nature.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 19From Bench to Podcast: He, Jin and Shi | Forum - 6 day(s) ago
Nature Biotechnology’s Forum podcast explores biotech’s latest scientific publications, found in Nature Biotechnology and elsewhere, through discussions with today’s leading researchers.
Source: shows.acast.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 9
In the journal Nature Biotechnology, scientists at Ludwig Cancer Research reported the development of an AI model to identify the most effective immune cells for cancer immunotherapy.
Source: www.azorobotics.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 98
Nature Biotechnology – EpiTrace infers cell mitotic age and evolution from single-cell ATAC-seq data.
Source: www.nature.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 12Ludwig Cancer Research - 9 day(s) ago
MAY 7, 2024, NEW YORK – Using artificial intelligence, Ludwig Cancer Research scientists have developed a powerful predictive model for identifying the most potent cancer killing immune cells for use in cancer immunotherapies. Combined with additional algorithms, the predictive model, described in the current issue of the journal Nature Biotechnology, can be applied to personalized cancer treatments that tailor therapy to the unique cellular makeup of each patient’s tumors. “The implementation of artificia
Source: www.ludwigcancerresearch.orgCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 295Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms - 10 day(s) ago
Nature Biotechnology – Tumor-reactive T cell receptors are predicted based on single-cell RNA sequencing and single-cell T cell receptor sequencing.
Source: www.nature.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 151Decrypting the molecular basis of cellular drug phenotypes by dose-resolved expression proteomics - 10 day(s) ago
Nature Biotechnology – Proteome-wide measurements of dose–response curves for 144 drugs reveal drug mechanisms of action.
Source: www.nature.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 6UNIGE's Synthetic Anticoagulant Provides Reliable Alternative To Heparin | Sepoy.net - 11 day(s) ago
Anticoagulant treatments are crucial for managing many conditions, such as heart disease, stroke and venous thrombosis. Current options, however, carry an
Source: sepoy.netCategories: General Medicine News, Future of MedicineTweet
Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture method https://t.co/dyNfpRb8kE https://t.co/d1XQCwFmjZ